183 related articles for article (PubMed ID: 35521768)
1. Two miRNAs enriched in plasma extracellular vesicles are potential biomarkers for thyroid cancer.
Delcorte O; Craps J; Mahibullah S; Spourquet C; D'Auria L; Van Der Smissen P; Dessy C; Marbaix E; Mourad M; Pierreux CE
Endocr Relat Cancer; 2022 May; 29(7):389-401. PubMed ID: 35521768
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Vesicles from Thyroid Carcinoma: The New Frontier of Liquid Biopsy.
Rappa G; Puglisi C; Santos MF; Forte S; Memeo L; Lorico A
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30841521
[TBL] [Abstract][Full Text] [Related]
4. Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules.
Rezaei M; Khamaneh AM; Zarghami N; Vosoughi A; Hashemzadeh S
BMC Cancer; 2019 Jul; 19(1):690. PubMed ID: 31307429
[TBL] [Abstract][Full Text] [Related]
5. Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome.
Hrustincova A; Krejcik Z; Kundrat D; Szikszai K; Belickova M; Pecherkova P; Klema J; Vesela J; Hruba M; Cermak J; Hrdinova T; Krijt M; Valka J; Jonasova A; Merkerova MD
Cells; 2020 Mar; 9(4):. PubMed ID: 32224889
[TBL] [Abstract][Full Text] [Related]
6. MiRNA let-7 from TPO(+) Extracellular Vesicles is a Potential Marker for a Differential Diagnosis of Follicular Thyroid Nodules.
Zabegina L; Nazarova I; Knyazeva M; Nikiforova N; Slyusarenko M; Titov S; Vasilyev D; Sleptsov I; Malek A
Cells; 2020 Aug; 9(8):. PubMed ID: 32824820
[TBL] [Abstract][Full Text] [Related]
7. Single-step RT-qPCR for detection of extracellular vesicle microRNAs in vivo: a time- and cost-effective method.
Lee H; He X; Le T; Carnino JM; Jin Y
Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L742-L749. PubMed ID: 32073880
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.
Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB
Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304
[TBL] [Abstract][Full Text] [Related]
9. A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules.
Liang M; Yu S; Tang S; Bai L; Cheng J; Gu Y; Li S; Zheng X; Duan L; Wang L; Zhang Y; Huang X
Front Genet; 2020; 11():449. PubMed ID: 32508877
[No Abstract] [Full Text] [Related]
10. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
[TBL] [Abstract][Full Text] [Related]
12. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing.
Dai D; Tan Y; Guo L; Tang A; Zhao Y
Eur J Endocrinol; 2020 Jan; 182(1):111-121. PubMed ID: 31721725
[TBL] [Abstract][Full Text] [Related]
13. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
[TBL] [Abstract][Full Text] [Related]
14. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma.
Li M; Song Q; Li H; Lou Y; Wang L
PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287
[TBL] [Abstract][Full Text] [Related]
16. Small RNA sequencing of extracellular vesicles identifies circulating miRNAs related to inflammation and oxidative stress in HIV patients.
Chettimada S; Lorenz DR; Misra V; Wolinsky SM; Gabuzda D
BMC Immunol; 2020 Nov; 21(1):57. PubMed ID: 33176710
[TBL] [Abstract][Full Text] [Related]
17. The characterization of extracellular vesicles-derived microRNAs in Thai malaria patients.
Ketprasit N; Cheng IS; Deutsch F; Tran N; Imwong M; Combes V; Palasuwan D
Malar J; 2020 Aug; 19(1):285. PubMed ID: 32778117
[TBL] [Abstract][Full Text] [Related]
18. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
[TBL] [Abstract][Full Text] [Related]
19. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
[TBL] [Abstract][Full Text] [Related]
20. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
